American Heart Association (AHA) Scientific Sessions
Event
Overview
includes event
Effect of fenofibrate therapy on cardiovascular disease in men vs women with type 2 diabetes in the ACCORD-Lipid Trial [presentation]
Hypertriglyceridemia and low HDL-C predicts fenofribrate response in the ACCORD-Lipid Trial [presentation]
Contact
held in geographic location
Chicago, IL
